Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 28, 2019; 25(12): 1492-1501
Published online Mar 28, 2019. doi: 10.3748/wjg.v25.i12.1492
Published online Mar 28, 2019. doi: 10.3748/wjg.v25.i12.1492
Figure 1 Effect of ursodeoxycholic acid on cell growth ability under the treatment of oleic acid.
A: Oil red O staining of LO2 cells after oleic acid (OA) treatment for 72 h. B: Cell viability of OA-induced LO2 cells measured using the MTT assay under the condition of concentration gradient of ursodeoxycholic acid (UDCA) for 48 h. C: Cell viability of LO2 cells measured using the MTT assay under the condition of oleic acid and 2 mmol/L UDCA for 24 h, 48 h, and 72 h. Scar bar: 20 μm. Data are shown as the mean ± SE. bP < 0.01, cP < 0.001 vs model group. Ctrl: Control; UDCA: Ursodeoxycholic acid; OA: Oleic acid.
- Citation: Hu J, Hong W, Yao KN, Zhu XH, Chen ZY, Ye L. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway. World J Gastroenterol 2019; 25(12): 1492-1501
- URL: https://www.wjgnet.com/1007-9327/full/v25/i12/1492.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i12.1492